Optimizing Health and Performance in Healthcare Workers

Overview

About this study

The purpose of this tudy is to evaluating IM8 Daily Ultimate Essentials vs Placebo.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: 

Age & Employment

  • Age 18–65 years.
  • Currently employed at Mayo Clinic Florida.

Health & Stability

  • Generally healthy or stable chronic conditions that do not interfere with the study.
  • No major surgeries or hospitalizations in the last 3 months.

Study Participation

  • Able to provide informed consent onsite and complete surveys in the required language and return for exit visit onsite.
  • Willing to adhere to study supplement intake, maintain current diet/exercise routines, and attend pre- and post- required study visits.

Exclusion Criteria:

  • Prior IM8 Daily Essentials Use
  • Medical or Medication Concerns
  • Pregnancy, breastfeeding, or planning pregnancy during the study.
    • Significant or unstable chronic diseases (e.g., advanced cardiac, renal, or liver conditions).
    • Known severe gastrointestinal disorders affecting nutrient absorption.
    • High-dose nutrient supplements or medications likely to interfere with the study product, unless approved by investigators.
  • Allergies & Sensitivities
    • Severe allergy (e.g., anaphylaxis) to ingredients in IM8 or related products.
  • Lifestyle Factors
    • Current substance abuse or other behaviors that may prevent adherence.
    • Participation in another clinical trial in the last 30 days.
  • Other Considerations
    • Any condition or factor that, in the investigator’s judgment, makes participation unsafe or compromises study integrity.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 3/13/2025. Questions regarding updates should be directed to the study team contact.
 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Dawn Mussallem, D.O.

Contact us for the latest status

Contact information:

Clinical Studies Unit

(904) 953-2255

More information

Publications

Publications are currently not available